Beta Blockers Flashcards
Pharmacologic properties of β-Blockers:
Relative affinity for β1 and β2 receptors Intrinsic sympathetic action Differences in solubility Membrane stabilizing activity Capacity to induce vasodilation α1 and β receptor blockade Difference in pharmacokinetic parameters
This genotype is a major determinant of interindividual metoprolol clearance:
CYP2D6
Initially, PVR is ____ and CO is ___ during β-blocker therapy:
increased; decreased
β-blocker with no effect on plasma renin activity:
Pindolol
MOA of β-blockers anti-HTN action:
Sustained low total PVR
Decreased renin release
Decreased NE release
Peripheral vasodilation (some)
NE release is decreased due to blockade of ____:
presynaptic β receptors
Non-selective β-blockers augment pressor response to ___ due to blockade of ___:
epinephrine; β2
β-blockers that stimulate NO production:
Celiprolol
Nebivolol
β-blockers with α1 antagonistic activity:
Carvedilol
Labetalol
β-blockers with Ca entry blockade activity:
Carvedilol
Betaxolol
β-blockers that open K channels:
Tilisolol
β-blocker that acts as β2 receptor agonist:
Celiprolol
β-blockers with membrane stabilizing activity:
PALOCA
Propranolol Alprenolol Labetalol Oxprenolol Carvedilol Acebutolol
Cardioselective β1 blockers:
CABNAME
Celiprolol Atenolol Betaxolol Nebivolol Acebutolol Metoprolol Esmolol
β1 blockers are preferred in patients with:
Bronchospasm
Diabetes
Peripheral vascular disease